Eli Lilly says its antibody therapy helps prevent Covid-19 in nursing homes

Eli Lilly and Company's monoclonal antibody combination therapy helped prevent symptomatic Covid-19 infection among nursing home residents and staff in a Phase 3 trial, the company announced on Thursday.